Page 1 of Clinical Trials for Bromfenac, 35 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
Last Updated: May 10, 2011
Condition(s): Inflammation; Pseudophakia
2
Completed
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
Last Updated: March 14, 2012
Condition(s): Cataracts
3
Completed
Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery
Last Updated: February 2, 2012
Condition(s): Cataract
4
Completed
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
Last Updated: June 8, 2009
Condition(s): Intraocular Pressure
5
Completed
Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care
Last Updated: June 8, 2009
Condition(s): Cataracts
6
Completed
Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers
Last Updated: February 6, 2012
Condition(s): Ocular Inflammation; Pain; Cataract
7
Completed
Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
Last Updated: July 20, 2011
Condition(s): Age-Related Macular Degeneration
8
Completed
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
Last Updated: August 26, 2011
Condition(s): Cataracts
9
Recruiting
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
Last Updated: November 20, 2011
Condition(s): Myopia
10
Completed
A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
Last Updated: August 26, 2011
Condition(s): Cataracts
11
Active, not recruiting
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-Operative Cystoid Macular Edema.
Last Updated: May 14, 2008
Condition(s): Cystoid Macular Edema
12
Completed
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
Last Updated: July 28, 2011
Condition(s): Post Operative Anterior Chamber Inflammation (Flare)
13
Active, not recruiting
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
Last Updated: July 28, 2011
Condition(s): Dry Eye Syndrome
14
Recruiting
Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
Last Updated: June 22, 2007
Condition(s): Diabetic Macular Edema
15
Completed
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Last Updated: February 17, 2009
Condition(s): Dry Eye Disease; Ocular Comfort
16
Completed
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
Last Updated: June 7, 2011
Condition(s): Pain; Inflammation
17
Completed
Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.
Last Updated: September 3, 2009
Condition(s): Diabetic Macular Edema
18
Completed
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
Last Updated: September 23, 2008
Condition(s): Cystoid Macular Edema,; Retinal Thickening
19
Completed
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
Last Updated: June 7, 2011
Condition(s): Allergic Conjunctivitis
20
Completed
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
Last Updated: January 15, 2007
Condition(s): Postoperative Complications; Cataract

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Bromfenac

Page 1 of Clinical Trials for Bromfenac, 35 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About